For: | Nagase N, Ikeda Y, Tsuji A, Kitagishi Y, Matsuda S. Efficacy of probiotics on the modulation of gut microbiota in the treatment of diabetic nephropathy. World J Diabetes 2022; 13(3): 150-160 [PMID: 35432750 DOI: 10.4239/wjd.v13.i3.150] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v13/i3/150.htm |
Number | Citing Articles |
1 |
Farideh Ghavidel, Hamed Amiri, Masoud Homayouni Tabrizi, Soodeh Alidadi, Hossein Hosseini, Amirhossein Sahebkar. The Combinational Effect of Inulin and Resveratrol on the Oxidative Stress and Inflammation Level in a Rat Model of Diabetic Nephropathy. Current Developments in Nutrition 2024; 8(1): 102059 doi: 10.1016/j.cdnut.2023.102059
|
2 |
Pradipta Paul, Ridhima Kaul, Ali Chaari. Renal Health Improvement in Diabetes through Microbiome Modulation of the Gut–Kidney Axis with Biotics: A Systematic and Narrative Review of Randomized Controlled Trials. International Journal of Molecular Sciences 2022; 23(23): 14838 doi: 10.3390/ijms232314838
|
3 |
Sayuri Yoshikawa, Kurumi Taniguchi, Haruka Sawamura, Yuka Ikeda, Ai Tsuji, Satoru Matsuda. Advantageous tactics with certain probiotics for the treatment of graft-versus-host-disease after hematopoietic stem cell transplantation. World Journal of Hematology 2023; 10(2): 15-24 doi: 10.5315/wjh.v10.i2.15
|
4 |
Xia-Qing Wu, Lei Zhao, Yan-Long Zhao, Xin-Yao He, Liang Zou, Ying-Yong Zhao, Xia Li. Traditional Chinese medicine improved diabetic kidney disease through targeting gut microbiota. Pharmaceutical Biology 2024; 62(1): 423 doi: 10.1080/13880209.2024.2351946
|
5 |
Ruijun Zhou, Wenbin Wen, Xiaoli Gong, Yanxia Zhao, Wei Zhang. Nephro‐protective effect of Daphnetin in hyperoxaluria‐induced rat renal injury via alterations of the gut microbiota. Journal of Food Biochemistry 2022; 46(12) doi: 10.1111/jfbc.14377
|
6 |
Xiaofang Wu, Lei Zhao, Yujiang Zhang, Kailong Li, Jurong Yang. The role and mechanism of the gut microbiota in the development and treatment of diabetic kidney disease. Frontiers in Physiology 2023; 14 doi: 10.3389/fphys.2023.1166685
|
7 |
Wei Yan, Ying Ge, Lina Wang, Yuntao Wang, Daikun He. Causal relationship of gut microbiota with diabetic nephropathy: a Mendelian randomization analysis. Frontiers in Microbiology 2024; 14 doi: 10.3389/fmicb.2023.1281361
|
8 |
Naoko Suga, Yuka Ikeda, Sayuri Yoshikawa, Kurumi Taniguchi, Haruka Sawamura, Satoru Matsuda. In Search of a Function for the N6-Methyladenosine in Epitranscriptome, Autophagy and Neurodegenerative Diseases. Neurology International 2023; 15(3): 967 doi: 10.3390/neurolint15030062
|
9 |
Rui Lin, Rongping Chen. Exploring the causal connection: insights into diabetic nephropathy and gut microbiota from whole-genome sequencing databases. Renal Failure 2024; 46(2) doi: 10.1080/0886022X.2024.2385065
|
10 |
Yi-Wei Kuo, Yen-Yu Huang, Shin-Yu Tsai, Jiu-Yao Wang, Jia-Hung Lin, Zun-Jie Syu, Hui-Shan Wang, Yu-Chieh Hsu, Jui-Fen Chen, Ko-Chiang Hsia, Hsieh-Hsun Ho. Probiotic Formula Ameliorates Renal Dysfunction Indicators, Glycemic Levels, and Blood Pressure in a Diabetic Nephropathy Mouse Model. Nutrients 2023; 15(12): 2803 doi: 10.3390/nu15122803
|
11 |
Banani Bhattacharjee, Arnob Chakrovorty, Maharaj Biswas, Asmita Samadder, Sisir Nandi. To Explore the Putative Molecular Targets of Diabetic Nephropathy and their Inhibition Utilizing Potential Phytocompounds. Current Medicinal Chemistry 2024; 31(24): 3752 doi: 10.2174/0929867330666230519112312
|
12 |
Peipei Wang, Ruixue Guo, Xiwen Bai, Wen Cui, Yiding Zhang, Huangmin Li, Jin Shang, Zhanzheng Zhao. Sacubitril/Valsartan contributes to improving the diabetic kidney disease and regulating the gut microbiota in mice. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1034818
|
13 |
Fei Huang, Jing Wei. Knockdown of UHRF1 ameliorates high glucose-induced podocyte injury by activating SIRT4. Molecular & Cellular Toxicology 2024; 20(3): 591 doi: 10.1007/s13273-023-00371-0
|